Matthews PC., Carlson JM., Beloukas A., Malik A., Jooste P., Ogwu A., Shapiro R., Riddell L., Chen F., Luzzi G., Jesuthasan G., Jeffery K., Jojic N., Ndung'u T., Carrington M., Goulder PJR., Geretti AM., Klenerman P.

Outcomes of chronic infection with hepatitis B virus (HBV) are varied, with increased morbidity reported in the context of human immunodeficiency virus (HIV) coinfection. The factors driving different outcomes are not well understood, but there is increasing interest in an HLA class I effect. We therefore studied the influence of HLA class I on HBV in an African HIV-positive cohort. We demonstrated that virologic markers of HBV disease activity (hepatitis B e antigen status or HBV DNA level) are associated with HLA-A genotype. This finding supports the role of the CD8(+) T-cell response in HBV control, and potentially informs future therapeutic T-cell vaccine strategies.

HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults.

Matthews PC., Carlson JM., Beloukas A., Malik A., Jooste P., Ogwu A., Shapiro R., Riddell L., Chen F., Luzzi G., Jesuthasan G., Jeffery K., Jojic N., Ndung'u T., Carrington M., Goulder PJR., Geretti AM., Klenerman P.

DOI

Type

Journal

Publication Date

Volume

Pages

Keywords